Cytokinetics, Incorporated
CYTK
$59.69
-$0.32-0.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -8.34% | 12.17% | -8.54% | -12.81% | 6.36% |
| Total Receivables | 882.52% | -78.50% | 317.99% | -87.92% | 6,723.77% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 30.63% | -34.96% | 26.38% | 3.58% | 129.20% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -6.18% | 10.24% | -7.27% | -13.71% | 8.77% |
|
|
|||||
| Total Current Assets | -6.18% | 10.24% | -7.27% | -13.71% | 8.77% |
| Net Property, Plant & Equipment | 1.04% | 4.95% | 1.19% | 2.58% | 0.29% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.16% | 15.51% | 14.62% | 64.79% | -0.26% |
| Total Assets | -0.84% | 17.21% | -3.04% | -9.82% | -2.39% |
|
|
|||||
| Total Accounts Payable | 1.15% | 36.09% | 16.40% | -31.55% | 75.88% |
| Total Accrued Expenses | 35.12% | 17.81% | 20.66% | -21.63% | 11.03% |
| Short-term Debt | 84.02% | -3.98% | 50.43% | 3.54% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 58.97% | 11.60% | 4.46% | 6.68% | 0.40% |
| Total Finance Division Other Current Liabilities | 51.25% | -67.08% | -81.21% | -6.42% | 244.91% |
| Total Other Current Liabilities | 51.25% | -67.08% | -81.21% | -6.42% | 244.91% |
| Total Current Liabilities | 42.43% | 8.45% | -17.94% | -11.10% | 63.62% |
|
|
|||||
| Total Current Liabilities | 42.43% | 8.45% | -17.94% | -11.10% | 63.62% |
| Long-Term Debt | 4.62% | 39.92% | 10.75% | -0.52% | 0.72% |
| Short-term Debt | 84.02% | -3.98% | 50.43% | 3.54% | -- |
| Capital Leases | -2.43% | -0.34% | -2.05% | 0.68% | -1.89% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.72% | 2.89% | 2.58% | 3.49% | 3.00% |
| Total Liabilities | 6.46% | 22.79% | 4.17% | -0.43% | 6.01% |
|
|
|||||
| Common Stock & APIC | 1.58% | 5.84% | 1.30% | 1.22% | 1.25% |
| Retained Earnings | -5.54% | -10.21% | -4.69% | -5.97% | -5.88% |
| Treasury Stock & Other | 1,752.94% | 121.52% | -110.23% | -35.57% | -55.49% |
| Total Common Equity | -26.58% | -41.33% | -38.40% | -96.80% | -873.13% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -26.58% | -41.33% | -38.40% | -96.80% | -873.13% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -26.58% | -41.33% | -38.40% | -96.80% | -873.13% |
|
|
|||||